Triple-Drug cocktail aims to stall endometrial cancer

NCT ID NCT01797523

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a combination of three drugs—everolimus, letrozole, and metformin—can help control advanced or recurrent endometrial cancer. The 62 participants had cancer that came back or spread and had limited prior treatments. The goal was to see how many patients had their cancer shrink or stop growing, and to check safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrial carcinoma endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lyndon B Johnson General Hospital

    Houston, Texas, 77026, United States

  • MD Anderson Cooper Cancer Center

    Voorhees Township, New Jersey, 08043, United States

  • Memorial City Medical Center

    Houston, Texas, 77024, United States

  • Sacred Heart Health Systems

    Pensacola, Florida, 32504, United States

  • The Woman's Hospital of Texas

    Houston, Texas, 77054, United States

  • University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States